UPC APP 39459/2024

—·EP2393417: ANALYTE SENSOR

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien: Kläger
Abbott Diabetes Care Inc.
Vertreter: Roland Küppers (Taylor Wessing); Alexander Rubusch (Taylor Wessing)
Beklagte
Sibio Technology Limited
Umedwings Netherlands B.V.
Vertreter: Thomas Gniadek (Simmons & Simmons)
Division: Dusseldorf LD
Richter: Berenice Thom · Legally Qualified Judge
Mélanie Bessaud · Legally Qualified Judge
Renaud Fulconis · Technically Qualified Judge
Technology: Biotechnology
Sprache: —
Erste Entscheidung: 3. Juli 2024

Entscheidungen

2024-07-03
VergleichGeneric application
Order by Düsseldorf Local Division (UPC_CFI_133/2024, 3 July 2024) confirming settlement between Abbott Diabetes Care Inc. and Sibio/Umedwings under R. 365.1(2) RoP in provisional measures proceedings over EP 2 393 417. A 20% reimbursement of court fees was ordered, the settlement having been reached at the oral hearing stage.
Rechtsfragen:Confirmation of settlement (R. 365.1 RoP)Court fee reimbursement (R. 370.9(c)(iii) RoP)Provisional measures proceedings

Dokumente